Ontology highlight
ABSTRACT:
SUBMITTER: Chung HC
PROVIDER: S-EPMC8411394 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Chung Hyun Cheol HC Bang Yung-Jue YJ S Fuchs Charles C Qin Shu-Kui SK Satoh Taroh T Shitara Kohei K Tabernero Josep J Van Cutsem Eric E Alsina Maria M Cao Zhu Alexander ZA Lu Jia J Bhagia Pooja P Shih Chie-Schin CS Janjigian Yelena Y YY
Future oncology (London, England) 20201110 5
Treatment options for patients with HER2-positive advanced gastric cancer are limited, and the prognosis for these patients is poor. Pembrolizumab has demonstrated promising antitumor activity in patients with advanced gastric or gastroesophageal junction adenocarcinoma as monotherapy, in combination with chemotherapy and in combination with trastuzumab. Combining pembrolizumab with trastuzumab and chemotherapy may therefore provide a benefit for patients with advanced HER2-positive gastric canc ...[more]